Checkout
Cart: $0.00 - (0 items )

Virta Health’s behavioral diabetes treatment service is now worth over $1 billion

Virta Health’s behavioral diabetes treatment service is now worth over billion A new $65 million investment led by the growth capital and public investment arm of Sequoia Capital will give Virta Health, a developer of a behavioral-focused diabetes treatment, a valuation of over $1 billion. Virta’s approach, which uses a combination of […]

Read More

Moderna claims 94% efficacy for COVID-19 vaccine, will ask FDA for emergency use authorization today

Moderna claims 94% efficacy for COVID-19 vaccine, will ask FDA for emergency use authorization today Drugmaker Moderna has completed its initial efficacy analysis of its COVID-19 vaccine from the drug’s Phase 3 clinical study, and determined that it was 94.1% effective in preventing people from contracting COVID-19 across 196 confirmed cases from […]

Read More

Oxford University’s COVID-19 vaccine shows high efficacy, and is cheaper to make and easier to store

Oxford University’s COVID-19 vaccine shows high efficacy, and is cheaper to make and easier to store Oxford University’s COVID-19 vaccine, being developed in partnership with drugmaker AstraZeneca, has shown to be 70.4% effective in preliminary results from its Phase 3 clinical trial. That rate actually includes data from two different approaches to […]

Read More

Pfizer and BioNTech to submit request for emergency use approval of their COVID-19 vaccine today

Pfizer and BioNTech to submit request for emergency use approval of their COVID-19 vaccine today Two of the companies behind one of the leading COVID-19 vaccine candidates will seek approval from the U.S. Food and Drug Administration for emergency use authorization (EUA) of their preventative treatment with an application to be delivered […]

Read More

Pfizer says its COVID-19 vaccine is 95% effective in final clinical trial results analysis

Pfizer says its COVID-19 vaccine is 95% effective in final clinical trial results analysis Drugmaker Pfizer has provided updated analysis around its COVID-19 vaccine Phase 3 clinical trial data, saying that in the final result of its analysis of the 44,000-participant trial, its COVID-19 vaccine candidate proved 95% percent effective. This is […]

Read More

Pfizer’s COVID-19 vaccine proves 90% effective in first results from Phase 3 clinical trial

Pfizer’s COVID-19 vaccine proves 90% effective in first results from Phase 3 clinical trial The COVID-19 vaccine being developed by Pfizer and its partner BioNTech has shown to be effective blocking vaccine in 90 percent of participants in its Phase 3 clinical trial, the companies announced on Monday. That’s based on data […]

Read More

Alphabet’s X details Project Amber, a quest for a single biomarker for depression that fell short of its goal

Alphabet’s X details Project Amber, a quest for a single biomarker for depression that fell short of its goal Alphabet’s X (the Google-owner’s so-called ‘Moonshot Factory’) published a new blog post today about Project Amber, a project it’s been working on over the past three years – the results of which it’s […]

Read More

Lawmakers Demand Scrutiny of Racial Bias in Health Algorithms

Lawmakers Demand Scrutiny of Racial Bias in Health Algorithms Four congressmembers say formulas that include race as a factor can hurt Black Americans’ access to care. Source: www.wired.com Lawmakers Demand Scrutiny of Racial Bias in Health Algorithms

Read More

United Airlines is making COVID-19 tests available to passengers, powered in part by Color

United Airlines is making COVID-19 tests available to passengers, powered in part by Color There’s still no clear path back to any sense of ‘business-as-usual’ as the COVID-19 pandemic continues, but United Airlines is embarking on a new pilot project to see if easy access to COVID-19 testing immediately prior to a […]

Read More

Daphne Koller: ‘Digital biology is an incredible place to be right now’

Daphne Koller: ‘Digital biology is an incredible place to be right now’ Working at the intersection of biology and computing may be the most exciting new spot for technologists at the moment. That’s the word from Daphne Koller, the founder and chief executive officer of Insitro — the biotech company that’s raised […]

Read More

Back to top